Javad Garousi (orcid.org/0000-0002-7224-6304)
Javad Garousi (orcid.org/0000-0002-7224-6304)
Verified email at igp.uu.se
Title
Cited by
Cited by
Year
Tailored doxorubicin‐H yaluronan conjugate as a potent anticancer glyco‐D rug: an alternative to prodrug approach
OP Oommen, J Garousi, M Sloff, OP Varghese
Macromolecular bioscience 14 (3), 327-333, 2014
482014
PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR: 2377 affibody molecules
J Garousi, KG Andersson, B Mitran, ML Pichl, S Ståhl, A Orlova, J Löfblom, ...
International journal of oncology 48 (4), 1325-1332, 2016
362016
ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers
J Garousi, S Lindbo, J Nilvebrant, M Åstrand, J Buijs, M Sandström, ...
Cancer research 75 (20), 4364-4371, 2015
342015
Radionuclide tumor targeting using ADAPT scaffold proteins: aspects of label positioning and residualizing properties of the label
S Lindbo, J Garousi, B Mitran, M Altai, J Buijs, A Orlova, S Hober, ...
Journal of Nuclear Medicine 59 (1), 93-99, 2018
262018
Preparation and biodistribution of [67Ga]-DTPA-gonadorelin in normal rats
A Jalilian, S Shanehsazzadeh, M Akhlaghi, J Garousi, S Rajabifar, ...
Journal of radioanalytical and nuclear chemistry 278 (1), 123-129, 2008
262008
The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
J Garousi, KG Andersson, JH Dam, BB Olsen, B Mitran, A Orlova, J Buijs, ...
Scientific reports 7 (1), 1-10, 2017
252017
Characterization of pure and antimony doped SnO2 thin films prepared by the sol-gel technique
AAJ NOVINROUZ, P Sarabadani, J Garousi
IRANIAN JOURNAL OF CHEMISTRY AND CHEMICAL ENGINEERING (IJCCE) 25 (2), 32-38, 2006
252006
Preparation, quality control and biodistribution studies of two [111In]-rituximab immunoconjugates
AR Jalilian, D Sardari, L Kia, P Rowshanfarzad, J Garousi, M Akhlaghi, ...
Scientia Pharmaceutica 76 (2), 151-170, 2008
242008
Influence of histidine-containing tags on the biodistribution of ADAPT scaffold proteins
S Lindbo, J Garousi, M Åstrand, H Honarvar, A Orlova, S Hober, ...
Bioconjugate chemistry 27 (3), 716-726, 2016
232016
Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX: 1 affibody molecule
H HONARvAR, J Garousi, E Gunneriusson, I HöIDéN-GUTHENbERG, ...
International journal of oncology 46 (2), 513-520, 2015
222015
Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
D Summer, J Garousi, M Oroujeni, B Mitran, KG Andersson, A Vorobyeva, ...
Molecular pharmaceutics 15 (1), 175-185, 2018
212018
Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR: 2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
KG Andersson, M Oroujeni, J Garousi, B Mitran, S Ståhl, A Orlova, ...
International journal of oncology 49 (6), 2285-2293, 2016
212016
Comparative evaluation of affibody molecules for radionuclide imaging of in vivo expression of carbonic anhydrase IX
J Garousi, H Honarvar, KG Andersson, B Mitran, A Orlova, J Buijs, ...
Molecular pharmaceutics 13 (11), 3676-3687, 2016
212016
Development of 111In labeled insulin for receptor imaging/therapy
A Jalilian, J Garousi, M Akhlaghi, P Rowshanfarzad
Journal of radioanalytical and nuclear chemistry 279 (3), 791-796, 2009
142009
Development of 153Sm-DTPA-rituximab for radioimmunotherapy
A Bahrami-Samani, M Ghannadi-Maragheh, AR Jalilian, H Yousefnia, ...
Nukleonika 54 (4), 271-277, 2009
142009
Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m
J Garousi, S Lindbo, B Mitran, J Buijs, A Vorobyeva, A Orlova, ...
Scientific Reports 7 (1), 1-11, 2017
112017
Influence of the N-terminal composition on targeting properties of radiometal-labeled anti-HER2 scaffold protein ADAPT6
J Garousi, S Lindbo, H Honarvar, J Velletta, B Mitran, M Altai, A Orlova, ...
Bioconjugate chemistry 27 (11), 2678-2688, 2016
112016
Comparative evaluation of two DARPin variants: effect of affinity, size, and label on tumor targeting properties
S Deyev, A Vorobyeva, A Schulga, G Proshkina, R Güler, J Löfblom, ...
Molecular pharmaceutics 16 (3), 995-1008, 2019
92019
Optimal composition and position of histidine-containing tags improves biodistribution of 99m Tc-labeled DARPin G3
A Vorobyeva, A Schulga, E Konovalova, R Güler, J Löfblom, M Sandström, ...
Scientific reports 9 (1), 1-11, 2019
82019
Comparison of tumor‑targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2
A Vorobyeva, A Sсhulga, E Konovalova, R Güler, B Mitran, J Garousi, ...
International journal of oncology 54 (4), 1209-1220, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20